CLINICAL_TRIALS
withdrawal
· 2013-08-20
Clinical Trial Update: Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children [Phase 1]
Summary
This clinical trial update indicates that a Phase 1 study of gabapentin to treat pruritus from burn injuries in children has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Hospital for Sick Children | Conditions: Pruritus | Phase 1 | Status: WITHDRAWN